drug

GIA632

1 story · latest Aug 21, 2026

Status: Investigational
Trials: 2 registered trials in coverage

Relationships

Developed by Novartis

Timeline

Novartis updates Leqvio label; MS study recruiting, thyroid study not yet recruiting

Aug 21Weekly roundup, 8 itemsGIA632 inclisiran

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.